Medications for Diabetic Retinopathy

4 results

  • ahzantive

    (aflibercept-mrbb)
    Valorum Biologics Inc
    AHZANTIVE is indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy.

  • cimerli

    (ranibizumab-eqrn)
    Coherus BioSciences Inc
    CIMERLI is indicated for treating neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.

  • eylea hd

    (aflibercept)
    Regeneron Pharmaceuticals, Inc
    EYLEA HD is indicated for the treatment of neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME), and diabetic retinopathy (DR).

  • lucentis

    (RANIBIZUMAB)
    Genentech, Inc.
    LUCENTIS is indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.